Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

The pace of clinical trial data generation and publication is an area of interest within clinical oncology; however, little is known about the dynamics and covariates of time to reporting (TTR) of trial results. To assess these, ClinicalTrials.gov was queried for phase three clinical trials for pati...

Full description

Bibliographic Details
Main Authors: Timothy A. Lin, Clifton David Fuller, Vivek Verma, Walker Mainwaring, Andres F. Espinoza, Austin B. Miller, Amit Jethanandani, Dario Pasalic, Prajnan Das, Bruce D. Minsky, Charles R. Thomas, David R. Fogelman, Vivek Subbiah, Ishwaria M. Subbiah, Ethan B. Ludmir
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
clinical trials
industry funding
cooperative groups
health policy
Online Access:https://www.mdpi.com/2072-6694/12/9/2636

Internet

https://www.mdpi.com/2072-6694/12/9/2636

Similar Items